Gossamer Bio (GOSS) Leases (2022 - 2025)
Gossamer Bio (GOSS) has 4 years of Leases data on record, last reported at $4.4 million in Q3 2025.
- For Q3 2025, Leases fell 27.75% year-over-year to $4.4 million; the TTM value through Sep 2025 reached $4.4 million, down 27.75%, while the annual FY2024 figure was $5.1 million, 63.24% up from the prior year.
- Leases reached $4.4 million in Q3 2025 per GOSS's latest filing, down from $4.6 million in the prior quarter.
- Across five years, Leases topped out at $7.9 million in Q1 2022 and bottomed at $1.7 million in Q2 2024.
- Average Leases over 4 years is $4.9 million, with a median of $4.8 million recorded in 2025.
- Peak YoY movement for Leases: plummeted 63.44% in 2024, then skyrocketed 174.85% in 2025.
- A 4-year view of Leases shows it stood at $5.9 million in 2022, then plummeted by 47.01% to $3.1 million in 2023, then surged by 63.24% to $5.1 million in 2024, then fell by 14.81% to $4.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $4.4 million in Q3 2025, $4.6 million in Q2 2025, and $4.8 million in Q1 2025.